Financing round brings in $20M for maker of genetic research tools

RainDance Technologies, which specializes in developing genetic research tools, secured $20 million in a Series E funding round. The Massachusetts-based firm plans to use the money to widen the reach of its products including its ThunderStorm sequencing and RainDrop digital PCR technologies. Proceeds will also go toward commercial operations and the expansion of production capacity.

View Full Article in:

Boston Herald · GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR